Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N9DU
|
||||
Former ID |
DIB020052
|
||||
Drug Name |
indirubin derivative E804
|
||||
Synonyms |
indirubin E804; compound 2 [PMID: 21632247]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531498] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H19N3O4
|
||||
InChI |
InChI=1S/C20H19N3O4/c24-11-12(25)9-10-27-23-18-14-6-2-4-8-16(14)21-19(18)17-13-5-1-3-7-15(13)22-20(17)26/h1-8,12,21,23-25H,9-11H2
|
||||
InChIKey |
CKLAPOFDFZKCPB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Interferon-induced, double-stranded RNA-activated protein kinase | Target Info | Inhibitor | [531498] | |
PANTHER Pathway | Apoptosis signaling pathway | ||||
Pathway Interaction Database | Signaling events mediated by TCPTP | ||||
Ceramide signaling pathway | |||||
PDGFR-beta signaling pathway | |||||
Reactome | ISG15 antiviral mechanism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.